FRM
SAGE
Fox Run Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48,950
| Closed | -$266K | – | 1187 |
|
|
2024
Q4 | $266K | Buy |
48,950
+32,579
| +199% | +$177K | 0.05% | 676 |
|
|
2024
Q3 | $118K | Sell |
16,371
-24,376
| -60% | -$176K | 0.03% | 727 |
|
|
2024
Q2 | $443K | Buy |
+40,747
| New | +$443K | 0.08% | 451 |
|
|
2024
Q1 | – | Sell |
-12,556
| Closed | -$272K | – | 1023 |
|
|
2023
Q4 | $272K | Buy |
+12,556
| New | +$272K | 0.07% | 533 |
|
|
2023
Q3 | – | Sell |
-9,606
| Closed | -$452K | – | 957 |
|
|
2023
Q2 | $452K | Buy |
+9,606
| New | +$452K | 0.13% | 316 |
|
|
2023
Q1 | – | Sell |
-17,148
| Closed | -$654K | – | 899 |
|
|
2022
Q4 | $654K | Buy |
+17,148
| New | +$654K | 0.26% | 91 |
|
|
2022
Q3 | – | Sell |
-17,298
| Closed | -$559K | – | 798 |
|
|
2022
Q2 | $559K | Buy |
17,298
+10,863
| +169% | +$351K | 0.28% | 97 |
|
|
2022
Q1 | $213K | Buy |
+6,435
| New | +$213K | 0.12% | 397 |
|
|
2021
Q4 | – | Sell |
-6,597
| Closed | -$292K | – | 678 |
|
|
2021
Q3 | $292K | Buy |
+6,597
| New | +$292K | 0.18% | 245 |
|
|
2020
Q2 | – | Sell |
-12,359
| Closed | -$355K | – | 309 |
|
|
2020
Q1 | $355K | Buy |
+12,359
| New | +$355K | 0.84% | 14 |
|
|
2019
Q3 | – | Sell |
-1,808
| Closed | -$331K | – | 535 |
|
|
2019
Q2 | $331K | Buy |
+1,808
| New | +$331K | 0.22% | 189 |
|
|
2017
Q3 | – | Sell |
-3,400
| Closed | -$271K | – | 844 |
|
|
2017
Q2 | $271K | Buy |
+3,400
| New | +$271K | 0.09% | 446 |
|